| Literature DB >> 31894741 |
Ting Yang1, Xin Sui1, Bing Yu1, Youqing Shen1, Hailin Cong1.
Abstract
Multi-target drugs have gained considerable attention in the last decade owing to their advantages in the treatment of complex diseases and health conditions linked to drug resistance. Single-target drugs, although highly selective, may not necessarily have better efficacy or fewer side effects. Therefore, more attention is being paid to developing drugs that work on multiple targets at the same time, but developing such drugs is a huge challenge for medicinal chemists. Each target must have sufficient activity and have sufficiently characterized pharmacokinetic parameters. Multi-target drugs, which have long been known and effectively used in clinical practice, are briefly discussed in the present article. In addition, in this review, we will discuss the possible applications of multi-target ligands to guide the repositioning of prospective drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Alzheimer's disease; Multitarget drugs; Parkinson's disease; cancer; neglected tropical diseases; pharmacokinetic parameters
Mesh:
Substances:
Year: 2020 PMID: 31894741 DOI: 10.2174/0929867327666200102120652
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530